191 related articles for article (PubMed ID: 3065728)
1. In vitro effects of B cell growth and maturation factor on B-CLL lymphocytes.
Karray S; Emilie D; Galanaud P
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):275-8. PubMed ID: 3065728
[TBL] [Abstract][Full Text] [Related]
2. Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines.
Lasky JL; Thorbecke GJ
Eur J Immunol; 1989 Feb; 19(2):365-71. PubMed ID: 2495224
[TBL] [Abstract][Full Text] [Related]
3. Cross-linking of membrane IgM on B CLL cells: dissociation between intracellular free Ca2+ mobilization and cell proliferation.
Hivroz C; Grillot-Courvalin C; Labaume S; Miglierina R; Brouet JC
Eur J Immunol; 1988 Nov; 18(11):1811-7. PubMed ID: 3144454
[TBL] [Abstract][Full Text] [Related]
4. Positive effects of interferon-alpha on B cell-type chronic lymphocytic leukemia proliferative response.
Karray S; Delfraissy JF; Merle-Beral H; Wallon C; Debre P; Galanaud P
J Immunol; 1988 Feb; 140(3):774-8. PubMed ID: 3257503
[TBL] [Abstract][Full Text] [Related]
5. Induction of differentiation in human leukemic B cells by interleukin 2 alone: differential effect on the expression of mu and J chain genes.
Emilie D; Karray S; Merle-Béral H; Debré P; Galanaud P
Eur J Immunol; 1988 Oct; 18(10):1479-83. PubMed ID: 3142777
[TBL] [Abstract][Full Text] [Related]
6. Regulatory effects of IL-4 on human B-cell response to IL-2.
Galanaud P; Karray S; Llorente L
Eur Cytokine Netw; 1990; 1(2):57-64. PubMed ID: 2102812
[TBL] [Abstract][Full Text] [Related]
7. B cell maturation in chronic lymphocytic leukemia. III. Effect of recombinant cytokines on leukemic B cell proliferation.
Nerl C; Janssen O; Kabelitz D
Leukemia; 1988 Dec; 2(12 Suppl):50S-56S. PubMed ID: 3059076
[TBL] [Abstract][Full Text] [Related]
8. Regulation by interleukin 2 of CD23 expression of leukemic and normal B cells: comparison with interleukin 4.
Hivroz C; Vallé A; Brouet JC; Banchereau J; Grillot-Courvalin C
Eur J Immunol; 1989 Jun; 19(6):1025-30. PubMed ID: 2526738
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of B-chronic lymphocytic leukemia populations by recombinant interleukin-4 and other defined growth-promoting agents.
Ghaderi AA; Richardson P; Cardona C; Millsum MJ; Ling N; Gillis S; Ledbetter J; Gordon J
Leukemia; 1988 Mar; 2(3):165-70. PubMed ID: 3126369
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory influence of IL-4 on human B cell responsiveness.
Jelinek DF; Lipsky PE
J Immunol; 1988 Jul; 141(1):164-73. PubMed ID: 2837507
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells.
Carlsson M; Tötterman TH; Rosén A; Nilsson K
Leukemia; 1989 Aug; 3(8):593-601. PubMed ID: 2787454
[TBL] [Abstract][Full Text] [Related]
12. Human T cell-replacing factor(s): a comparison of recombinant and purified human B cell growth and differentiation factors.
Smith SH; Shields JG; Callard RE
Eur J Immunol; 1989 Nov; 19(11):2045-9. PubMed ID: 2689186
[TBL] [Abstract][Full Text] [Related]
13. Phorbol ester and B cell-stimulatory factor synergize to induce B-chronic lymphocytic leukemia cells to simultaneous immunoglobulin secretion and DNA synthesis.
Carlsson M; Matsson P; Rosén A; Sundström C; Tötterman TH; Nilsson K
Leukemia; 1988 Nov; 2(11):734-44. PubMed ID: 3263557
[TBL] [Abstract][Full Text] [Related]
14. A further characterization of B-CLL lymphocytes: phenotypic and functional studies.
Merle-Béral H
Nouv Rev Fr Hematol (1978); 1990; 32(5):319-21. PubMed ID: 2099403
[TBL] [Abstract][Full Text] [Related]
15. Sequential effect of a high molecular weight B cell growth factor and of interleukin 2 on activated human B cells.
Vazquez A; Auffredou MT; Gerard JP; Delfraissy JF; Galanaud P
J Immunol; 1987 Oct; 139(7):2344-8. PubMed ID: 3116080
[TBL] [Abstract][Full Text] [Related]
16. Functional heterogeneity of B-CLL lymphocytes: dissociated responsiveness to growth factors and distinct requirements for a first activation signal.
Karray S; Merle-Béral H; Vazquez A; Gerard JP; Debre P; Galanaud P
Blood; 1987 Oct; 70(4):1105-10. PubMed ID: 3115334
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of recombinant IL 2 and interferon-gamma on the proliferation of human monoclonal lymphocytes.
Karray S; Vazquez A; Merle-Beral H; Olive D; Debre P; Galanaud P
J Immunol; 1987 Jun; 138(11):3824-8. PubMed ID: 3108376
[TBL] [Abstract][Full Text] [Related]
18. Leukemic cells from progressive B-CLL respond strongly to growth stimulation in vitro.
Aguilar-Santelises M; Mellstedt H; Jondal M
Leukemia; 1994 Jul; 8(7):1146-52. PubMed ID: 8035606
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the proliferative response of human B lymphocytes to B cell growth factor by transforming growth factor-beta.
Petit-Koskas E; Génot E; Lawrence D; Kolb JP
Eur J Immunol; 1988 Jan; 18(1):111-6. PubMed ID: 3257917
[TBL] [Abstract][Full Text] [Related]
20. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
Djurdjevic P; Zelen I; Ristic P; Baskic D; Popovic S; Arsenijevic N
Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]